Isopropylphenidate Hydrochloride
$50.00 – $400.00
Isopropylphenidate Hydrochloride salt. Mixture of isomers.
Other Names: IPPD, IPH
| IUPAC Name |
propan-2-yl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate hydrochloride |
|---|---|
| CAS Number |
1262795-94-7 |
| Molecular Formula |
C16H23NO2HCl |
| Molar Mass |
297.82 |
| Purity |
97% |
| Formulation |
White Powder |
Isopropylphenidate Hydrochloride salt. Analytical reference standard, comparable to Cayman Chemical’s, but much cheaper.
Up to 10 percent of the product is isopropylphenidate sulfate. This is essentially the same as isopropylphenidate hydrochloride, only the counterion is different.
Not for in vivo use. No shipping outside the US.
Note: FTIR spectra of the isopropylphenidate will be added as soon as we get the lab results from Kykeon Analytics.
You get a really good deal
For all products, you have the option for free USPS First Class shipping, or $8 for USPS Priority Mail.
Wikipedia Article Text
Isopropylphenidate (also known as IPH and IPPD) is a piperidine based stimulant drug, closely related to methylphenidate, but with the methyl ester replaced by an isopropyl ester. It has similar effects to methylphenidate but with a longer duration of action,[1][2] and was banned in the UK as a Temporary Class Drug from April 2015 following its unapproved sale as a designer drug.[3]
It has been researched as potential methylphenidate replacement for ADHD and narcolepsy, because of fewer side effects.[4][2]
Isopropylphenidate (also known as IPH and IPPD) is a piperidine based stimulant drug, closely related to methylphenidate, but with the methyl ester replaced by an isopropyl ester. It has similar effects to methylphenidate but with a longer duration of action,[1][2] and was banned in the UK as a Temporary Class Drug from April 2015 following its unapproved sale as a designer drug.[3]
It has been researched as potential methylphenidate replacement for ADHD and narcolepsy, because of fewer side effects.[4][2]
Wikipedia References
- Markowitz JS, Zhu HJ, Patrick KS (December 2013). "Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability" (PDF). Journal of Child and Adolescent Psychopharmacology. 23 (10): 648–54. doi:10.1089/cap.2013.0074. hdl:2027.42/140321. PMID 24261661.
- US application 20120245201, Markowitz JS, Patrick KS, Zhu H, "Isopropylphenidate for Treatment of Attention-Deficit/Hyperactivity Disorder and Fatigue-Related Disorders and Conditions", published 2012-09-27
- "Methylphenidate-based NPS: A review of the evidence of use and harm" (PDF). Advisory Council on the Misuse of Drugs. 31 March 2015.
- Florence Levy (July 2014). "Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder". Pharmgenomics Pers Med: 349–356.
Reviews
There are no reviews yet.